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Abstract
Intake of trans fatty acids (TFA), which are consumed by eating foods made from partially hydrogenated vegetable oils, is
associated with a higher risk of cardiovascular disease. This relation can be explained by many factors including TFA’s
negative effect on endothelial function and reduced nitric oxide (NO) bioavailability. In this study we investigated the effects
of three different TFA (2 common isomers of C18 found in partially hydrogenated vegetable oil and a C18 isomer found
from ruminant-derived—dairy products and meat) on endothelial NF-kB activation and nitric oxide (NO) production. Human
endothelial cells were treated with increasing concentrations of Elaidic (trans-C18:1 (9 trans)), Linoelaidic (trans-C18:2 (9
trans, 12 trans)), and Transvaccenic (trans-C18:1 (11 trans)) for 3 h. Both Elaidic and Linoelaidic acids were associated with
increasing NF-kB activation as measured by IL-6 levels and phosphorylation of IkBa, and impairment of endothelial insulin
signaling and NO production, whereas Transvaccenic acid was not associated with these responses. We also measured
superoxide production, which has been hypothesized to be necessary in fatty acid-dependent activation of NF-kB. Both
Elaidic acid and Linoelaidic acid are associated with increased superoxide production, whereas Transvaccenic acid (which
did not induce inflammatory responses) did not increase superoxide production. We observed differential activation of
endothelial superoxide production, NF-kB activation, and reduction in NO production by different C18 isomers suggesting
that the location and number of trans double bonds effect endothelial NF-kB activation.
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Introduction
Trans fatty acids (TFA) include monounsaturated fatty acids or
polyunsaturated fatty acids that contain at least one carbon-carbon
trans double bond. Most of the dietary TFA are derived from
partial hydrogenation of vegetables oil or from ruminant-derived
foods (dairy products and meat). TFA are widely used by the food
industry in the generation of baked goods, deep-fried foods, and
packaged snacks. It is estimated that TFA contribute up to 4–12%
of total dietary fat intake in the US population [1]. During the past
20 years, epidemiologic studies have identified consumption of
TFA as an important modifiable risk factor in the development of
cardiovascular disease [2,3]. Recently, the use and presence of
TFA in the diet has been the object of much public health
discussions.
Consumption of TFA raises levels of LDL cholesterol and
reduces HDL cholesterol levels to a greater extent when compared
with the consumption of equal amounts of energy from saturated
or mono-or polyunsaturated fat. The relationship between intake
of TFA and incidence of cardiovascular disease however, has been
greater than predicted by changes in serum lipids alone, suggesting
that TFA influence other risk factors for cardiovascular disease.
TFA consumption is known to influence multiple risk factors
besides changes in lipid/lipoproteins, including increased systemic
inflammation [4], increased thrombogenesis and reduced endo-
thelial function [5], all of which in combination or individually
contribute to increased cardiovascular risk. Experimental studies
suggest that TFA exert their multiple effects by influencing
metabolic and signaling pathways in hepatocytes, monocytes,
adipocytes and in endothelial cells. The precise molecular
pathways through which TFA influence these cell types are
unknown.
Endothelial dysfunction can be described as impairment in the
generation and function of nitric oxide (NO) as a vasodilator and
vascular homeostatic agent. A reduction in NO bioavailability
greatly increases the risk of developing atherosclerosis and
hypertension. Endothelial nitric oxide synthase (eNOS) synthesizes
NO in response to many agonists including fluid shear stress,
bradykinin, and insulin, which increases NO production in
endothelial cells through an Insulin Receptor Substrate-1 (IRS-1)
and phosphatidylinositol 3-kinase (PI3-kinase) dependent pathway
that results in phosphorylation of endothelial nitric oxide synthase
(eNOS) by Akt in a calcium-independent manner [6,7]. We have
previously shown that the dietary saturated fat, palmitate,
attenuates endothelial insulin signaling and NO production by
first activating NF-kB signaling which results in a reduction in
IRS-1/pAkt/peNOS signaling. Based on these results we asked
whether the TFA would reduce endothelial NO levels by first
activating NF-kB.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29600In endothelial cells, TFA have been shown to increase markers
of endothelial dysfunction including E-selectin, ICAM, and impair
flow-mediated vasodilation (measure of vascular NO production)
in humans [5,8]. In this study we chose three different TFA, all
isomers of C18 – trans-C18:1 (9 trans), trans-C18:2 (9 trans, 12
trans), trans-C18:1 (11 trans). Trans-C18:1 (trans 9), also known as
Elaidic acid, is a common TFA formed by partial hydrogenation
of vegetable oil, trans-C18:2, also known as Linoelaidic acid, is
commonly found during the process of heating vegetable oils
(frying or baking food in vegetable oil) resulting in generation of
two trans double bonds, trans-C18:1 (trans11), also known as
Transvaccenic acid, is a model of ruminant-derived TFA, which
are produced by bacteria in the ruminant stomach. Ruminant
derived TFA are found in dairy products or in meat tissue,
however human consumption of ruminant-derived TFA is
generally low due to the low concentration (1%). All these TFA
have 18 carbons, however differ in the location of the trans double
bonds. We asked whether these different TFA are associated with




(Beverly, MA) Human IL-6 ELISA kits from R and D Systems
(Minneapolis, MN), and phospho-IkBa Case
TM Cellular Activation
of Signaling ELISA SuperArray Bioscience Corporation (Frederick,
MD). Total Akt and pAkt(serine 473) ELISA kits were obtained
from Biosource (Camarillo, CA). The spin trap 1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) was pur-
chased from Alexis Biochemical (Lausen, Switzerland). Sodium
DETC was obtained from Alexis Biochemical (Lausen, Switzer-
land). FeSO4 7H2O was purchased from Sigma (St Louis, MO).
Superoxide dismutase (PEG-SOD), Diphenylene idonium (DPI),
and LPS were obtained from Sigma-Aldrich. Dihydroethidium
(DHE) was purchased from (Molecular Probes/Invitrogen, Eugene
Oregon).
Palmitic (C 16:0), C18:1T or 11-trans-octadecenoic (Transvac-
cenic), C 18:1T or 9-trans-octadecenoic (Elaidic), C18:2 (Linoleic),
C18:2 Linoelaidic (9-trans 12 trans octadecadienoic) fatty acids
were obtained from Nu-Chek Prep, Inc. (Elysian, MN) and BSA
(FFA-free) was purchased from Roche (Indianapolis, In). FFA were
dissolved in 0.1 M NaOH at 70uC and then complexed with 10%
BSA at 55uC for 10 min to achieve a final fatty acid concentration
of 100 mM as described previously [9]. Stock solutions of 5 mM
FFA with 10% BSA and 10%BSA control solutions were prepared
1 d prior to experiments. Fatty acid preparations were assessed for
LPS contamination using Amebocyte Lysate Test (Biowhittaker).
Cell Culture
Human microvascular endothelial cells (HMEC) were pur-
chased from (Invitrogen-Cascade Biological) and were cultured in
RPMI 1640 supplemented with 10% fetal bovine serum (Hyclone
Laboratories, Logan, UT) and 12 mg/ml of bovine brain extract
(Clonetics, Walkersville, MD), L-glutamine (2 mM), sodium
pyruvate (1 mM) and nonessential amino acids in the presence
of penicillin (100 units/ml) and maintained at 37uCi n5 %C O 2.
All Western bots were performed as described [10], using equal
amounts of total protein for each condition and experiment. SDS
gel electrophoresis was performed using a 4% by 20% gradient
gel. Total RNA was extracted using RNeasy Mini Kit (Qiagen)
and Human TNFa, ICAM, and iNOS primer pairs were
purchased from Applied Biosystems.
Superoxide measurement
Endothelial superoxide radical was measured by electron spin
resonancespectroscopy(ESR)usingthe spin trap (CMH)[11,12,13].
HMEC were processed by washing once with ice cold PBS and
removed by scrapping. After centrifugation the cells were
resuspended in Krebs-HEPES buffer and 0.1 mM diethylenetria-
mine-penta-acetic acid (DTPA) was used to inhibit iron-catalyzed
oxidation of the CMH trap. Electron spin resonance spectroscopy
(ESR) studies were performed on a table-top x-band spectrometer
Miniscope(Magnettech, Germany). Recordings were made at room
temperature using a small capillary tube. Instrument settings were
biofield 3350, Sweep 60 G, Microwave frequency 9.78 Ghz,
microwave power 20 mW, and kinetic time of 10 min.
Nitric Oxide Measurements
Nitric oxide was measured using the spin trap Fe(DETC)2 which
wasfirstreported andvalidatedbyKleschyovetal [14].Preparation
of colloid Fe(DETC)2: Sodium DETC (3.6 mg) and FeSO4 7H20
(2.25 mg) were dissolved under argon gas in 10 ml of ice cold
Krebs-Hepes buffer [15] (consisting of, in mM: NaCl 99, KCl 4.7,
MgSO4 1.2, KH2PO4 1.0, CaCl2 1.9, NaHCO3 25, glucose 11.1,
and Na-Hepes 20, pH7.4) These were rapidly mixed to obtain a
pale yellow-brown colored Fe(DETC)2 solution which was used
immediately. After removing cell culture media, endothelial cells
were washed once with PBS and 100 ml of Krebs-hepes buffer was
added to the cell culture plates. Colloid Fe(DETC)2 was then added
to final concentration of 286 mM and incubated at 37uC for
90 minutes. Electron spin resonance spectroscopy (ESR) studies
were performed on a table-top x-band spectrometer Miniscope
(Magnettech, Germany). Recordings were made at 77 K using a
Dewar flask. Instrument settings were 10 mW of microwave power,
1 mT of amplitude modulation, 100 kHz of modulation frequency,
20 s of sweep time and 10 number of scans.
Statistics
In all experiments, densitometry/ELISA measurements were
normalized to controls incubated with vehicle and percent change
relative to the control condition was calculated. Analysis of the
results was performed using the STATA8 statistical package. Data
are expressed as mean 6 SEM, and values of p,0.05 were
considered statistically significant. A two-tailed t-test was used to
compare mean values from studies involving two experimental
groups. Data were analyzed by two-way analysis of variance using
the Bonferoni-post-hoc comparison test when appropriate.
Results
Trans-fatty acids induce NF-kB responses in human
endothelial cells
We first asked whether TFA, found in a Western diet, are
associated with increased endothelial NF-kB activation. We tested
three different TFA: trans-C18:1 (11 trans), trans-C18:2 (9 trans, 12
trans) and trans-C18:1T (9 trans) all different isomers of C18. We
used palmitate as a control since we have previously shown that
palmitic acid increases endothelial NF-kB activation in a dose
dependent manner [16]. C18:2 in the cisconfiguration (linoleic) was
also used as a negative control since this polyunsaturated fat does
not increase endothelial NF-kB signaling. We chose an incubation
period of 3 h with BSA-complexed fats, since previous studies
demonstratedanapoptoticeffect inendothelialcellsfortime periods
greater than 6–8 h. To assess NF-kB activation in endothelial cells
we measured the phosphorylation of IkBa and production of IL-6
(NF-kB dependent cytokine). Both trans-C18:2 (9 trans, 12 trans)
and trans-C18:1 (9 trans) increased phospho-IkBa and IL-6 levels in
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(11 trans) (Transvaccenic acid) did not increase phospho-IkBa or
IL-6 levels (Figure 1A, B). As expected, palmitate increased NF-kB
signalingin a dose-dependent manner (Figure 1).Both Elaidic(trans-
C18:1 (9 trans)) and Linoelaidic (trans-C18:2 (9 trans, 12 trans)) at
concentration of 100 mM, increased NF-kB-dependent gene
expression (TNFa, ICAM, and iNOS), a response not seen with
Linoleic or Transvaccenic acid (Figure 1C). Thus, common
‘‘industrial TFA’’ are associated with increased endothelial
inflammation, whereas ruminant derived TFA (transvaccenic acid)
does not. Furthermore, the location of the trans-double bond had a
differential inflammatory effect on endothelial cells.
Effect of trans fats on endothelial insulin signaling
We have previously shown that in endothelial cells, palmitate-
mediated activation of NF-kB signaling is associated with reduced
insulin-mediated Akt and eNOS signaling in endothelial cells [16].
We next investigated whether TFA would also reduce endothelial
insulin signaling. Endothelial cells were treated with 100 mMo f
TFA for 3 h and insulin-mediated signaling was assessed following
treatment with vehicle or 100 nM insulin for 15 minutes. As
expected and consistent with published results, pre-treatment with
100 mM of palmitate resulted in reduced insulin-mediated Akt and
eNOS phosphorylation in the absence of any change in total eNOS
or Akt levels. Although insulin stimulation increases phosphoryla-
tion of Akt serine 473 and eNOS serine 1177, pretreatment with
trans-C18:2 (9 trans 12 trans) and trans-C18:1 (trans 9) are associated
with impairment of endothelial insulin signaling, however, we did
notseeaninhibitoryeffectwithtrans-C18:1(11trans)(Transvaccenic
acid) or with Linoleic acid (Figure 2A and 2B). TFA, which are
associated with increased NF-kB activation are also associated with
reduced endothelial insulin signaling.
Effect of TFA on NO production
We next determined the effect of TFA on endothelial NO
production as measured by ESR using the spin trap Fe(DETC)2,
Figure 1. Effect of TFA on endothelial NF-kB signaling. Human endothelial cells were treated with increasing concentrations of palmitate,
linoleic acid, transvaccenic (trans-C18:1 (11 trans)), linoelaidic (trans-C18:2 (9 trans, 12 trans)), and elaidic (trans-C18:1 (9 trans)) for 3 h. All fatty acids
were initially complexed with BSA and in the control condition cells were treated with BSA alone for 3 h. A. Phospho-IkBa levels were measured
using an ELISA assay. Fold-increase over the control (BSA alone) condition was calculated. (n=3, *p,0.05). B. IL-6 levels as measured by ELISA. (n=3,
*p ,0.05). C. Expression levels of TNFa, ICAM, and iNOS in response to 100 mM of fat. (n=3, * p,0.05).
doi:10.1371/journal.pone.0029600.g001
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expected palmitate pretreatment is associated with reduced
insulin-mediated NO production (Figure 2C) whereas pretreat-
ment with Linoleic acid (C18:2) or transvaccenic acid did not
reduce insulin mediated NO production. TFA associated with
increased endothelial NF-kB activation (trans-C18:2 and trans-
C18:1) are also associated with reduced insulin-mediated NO
production, an expected result since we have previously linked NF-
kB activation with a reduction in NO production.
Effect of TFA on superoxide production
In previous studies, palmitate increases NF-kB activation via a
mechanism dependent on NADPH oxidase-derived superoxide
production [19]. We next asked whether TFA would also increase
reactive oxygen species (ROS) production. Endothelial cells were
treated with 100 mM of TFA and ROS production was measured
by ESR and the spin trap CMH. As expected 100 mM of palmitate
increased ROS production 2-fold, whereas Linoleic acid and
Transvaccenic acid did not increase ROS production. Trans-C18:1
(9 trans) and trans-C18:2 (9 trans, 12 trans) were associated with a
2-fold increase in ROS production as measured by ESR. TFA,
which are associated with increased endothelial NF-kB are also
associated with increased ROS production. Pretreatment with
superoxide dismutase (SOD) or incubation with diphenylene
iodnium (DPI) attenuates palmitate-dependent activation of
endothelial inflammation [19] and as expected, similar pretreat-
ment attenuates activation of endothelial NF-kB (at the level of IL-
6 production) in the presence of trans-C18:1 (9 trans) and trans-
C18:2 (9 trans 12 trans), suggesting that these TFA also activate
NF-kB via a mechanism dependent on ROS production
(Figure 3B).
Discussion
Numerous epidemiological studies have correlated elevated
dietary intake of TFA with increased mortality and morbidity from
cardiovascular disease. In this study we examined three TFA for
their ability to activate endothelial NF-kB and subsequently
Figure 2. Effect of TFA on endothelial insulin signaling. Human endothelial cells were treated with either 100 mM of palmitate, linoleic acid,
transvaccenic (trans-C18:1 (11 trans)), linoelaidic (trans-C18:2 (9 trans, 12 trans)), and elaidic (trans-C18:1 (9 trans)) for 3 h and then stimulated with
insulin 100 nM or vehicle for 15 min. A. Cell lysates were made and were analyzed for insulin-mediated phosphorylation of serine 473 Akt and total
Akt by ELISA. Fold increase over vehicle condition was calculated. (n=3, *p,0.05) B. Cell lysates were analyzed for insulin-mediated phosphorylation
of serine 1177 eNOS and total eNOS by Western blot. Representative phospho-eNOS Western blots are shown. Fold increase over vehicle condition
was calculated (n=3, *p,0.05). C. Insulin-mediated nitric oxide production was measured by ESR using the spin trap Fe(DETC)2 (n=3, *p,0.05).
doi:10.1371/journal.pone.0029600.g002
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C18:2 (9 trans 12 trans)(Linoelaidic) and trans-C18:1 (9 trans)
(Elaidic) are associated with increased NF-kB activation, and
reduced endothelial insulin signaling and NO production,
whereas, trans-C18:1 (11 trans)(Transvaccenic) is not associated
with either of these responses. Furthermore, both Linoelaidic and
Elaidic acids increased endothelial ROS production, a response,
hypothesized to be necessary in activating endothelial NF-kB.
These results suggest that different isomers of C18 are capable of
eliciting differential effect on endothelial function.
Exposure of endothelial cells to palmitate, glucose, TNF-a all
mediators of insulin resistance, results in activation of NF-kB and
increased expression of adhesion molecules [20,21], an early
marker for atherosclerosis. In addition, we have shown that these
mediators of insulin resistance are also associated with reduced
endothelial NO production [6,22]. Raising systemic inflammation
by injection of S. typhi vaccine has been shown to impair
endothelial function in human volunteers [23], suggesting that
systemic inflammation effects nitric oxide bioavailability. The
mechanism underlying endothelial dysfunction may therefore
involve activation of NF-kB, which by inhibiting IRS-1/PI3-
kinase signal transduction, attenuates NO production. Attenuation
of endothelial NF-kB signaling (using a mutant of IkBa) in the
presence of palmitate restores endothelial NO content [24], which
further supports a mechanistic link between NF-kB and reduced
NO levels. In the present study, TFA which are associated with
increased NF-kB signaling are associated with reduced endothelial
NO signaling. The relationship between trans-C18:1 (Elaidic)and
trans-C18:2 (Linoelaidic) on endothelial NF-kB activation have
been demonstrated before [8], and our studies are in support of
the previous observation. However, we extend this finding by
linking NF-kB activation with reduced endothelial insulin
signaling and NO production.
The relationship between total industrial TFA (partially
hydrogenated vegetable oil) consumption and cardiovascular
disease has been well studied. Less is known, however, about the
vascular effects of particular TFA isomers. During the partial
hydrogenation of vegetable oil (industrial TFA) such as trans-18:1,
the location of the double bond vary from carbon number 4 to 16,
however, the double bonds are mainly centered on carbon 9 or 10.
The distribution depends first on the starting vegetable oil and
secondly, on the extent of hydrogenation. Whether a particular
trans-C18:1 isomer has a greater cardiovascular risk remains an
unanswered question, however, maybe difficult to answer using
population based studies. Our current in vitro studies, however,
support the hypothesis that the different trans-C18:1 isomers have
a differential effect on endothelial NF-kB activation and on NO
and superoxide production. Furthermore, these differential effects
may serve as ‘‘mechanistic’’ explanations for differential clinical
risk of the different TFA isomers and suggests that some C18:1
isomers (eg. Transvaccenic acid) may have limited effects on
endothelial cells.
The effect of ruminant derived TFA (eg. Transvaccenic acid) on
cardiovascular disease risk or endothelial dysfunction have not
been clearly defined. Tardy et al. recently reviewed 5 studies,
which looked for an association between consumption of ruminant
derived TFA and cardiovascular risk [25]. In contrast to the
industrial TFA, no conclusive evidence is currently available which
links ruminant derived TFA with cardiovascular risk. Ruminant
derived TFA may be less deleterious especially at lower level and
consumption of dairy fats could be tolerated in respect to
cardiovascular risk. Furthermore, no specific relationships between
ruminant TFA and systemic inflammation or endothelial dysfunc-
tion have been defined in small observational studies. Our current
in vitro studies with Transvaccenic acid (our model of ruminant
derived TFA) support this observation and are consistent with the
observed clinical studies.
The precise molecular pathways by which TFA increase NF-kB
signaling remains unanswered, however a few possible mecha-
nisms have been proposed. First, many dietary fats are known to
incorporate into cell membrane and lipid rafts, which may alter
cell receptor function. In vitro studies in human aortic endothelial
cells demonstrated increased incorporation of trans-C18:2 into
cellular membrane, which was associated with increased expres-
sion of adhesion molecules [8]. Second, TFA may alter fatty-acid
metabolism by reducing fatty acid uptake and esterification. Third,
Figure 3. Effect of TFA on endothelial superoxide production. Human endothelial cells were treated with either 100 mM of palmitate, linoleic
acid, transvaccenic (trans-C18:1 (11 trans)), linoelaidic (trans-C18:2 (9 trans, 12 trans)), and elaidic (trans-C18:1 (9 trans)) for 3 h. A. Superoxide levels
were measured by ESR and the spin trap CMH. Fold increase over the control condition (BSA alone) was calculated. (n=3, *p,0.05, compared to BSA
control). B. Cells were pretreated with either of two inhibitors of superoxide (SOD, 100 Units/ml or DPI 25 mM) prior to stimulation with Elaidic or
Linoelaidic acid. IL-6 levels as measured by ELISA.
doi:10.1371/journal.pone.0029600.g003
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immune receptor, toll like receptor 4 in mediating the effects of
saturated fat in activation of NF-kB [24]. It is possible that TFA
may directly activate TLR4 or indirectly by altering lipid raft
function. Finally, our laboratory and others have demonstrated a
potential role for NADPH oxidase-dependent ROS generation in
mediating the inflammatory effects of dietary fats [19]. Reduction
of NAPDHoxidase signaling or ROS generation attenuates the
ability of palmitate to increase NF-kB signaling. In the current
study we also observed a correlation with the generation of ROS
and endothelial NF-kB activation.
Clinical studies have demonstrated a profound effect of FFA on
NO production. In normal patient volunteers, the ingestion of a
single high-fat meal transiently impairs endothelial function as
measured by flow-mediated brachial artery vasodilation [26].
Infusion of high doses of intralipid plus heparin into normal
volunteers raises circulating FFA concentrations from a starting
concentration of 350 mM to a peak of 3800 mM [27]. Methacho-
line-induced vasodilation was reduced by as much as 20%,
indicating that elevated FFA levels induce endothelial dysfunction
[27]. In a separate study, raising FFA levels resulted in impairment
of basal and insulin-mediated NO production [28]. These human
studies suggest that the production of NO is impaired in the
presence of high circulating levels of FFA.
We used doses of individual TFA between 25–100 mM in our in
vitro studies, which are higher than found in humans. A diet rich
in various trans-C18:1 has been shown to increase the serum levels
of all TFA to between 40–120 mM [29], suggesting that the in
vitro study TFA doses maybe 2–4 times higher than found in
human serum. In vitro studies are limited in that higher
concentrations are necessary in order to observe a biologic effect
and need to be confirmed in dietary studies.
In conclusion, the present studies demonstrate that two
common industrial TFA isomer of C18 increase NF-kB activation
and impair insulin-mediated NO production in endothelial cells.
These studies suggest a differential effect of C18 isomers and that
the location and number of trans double bonds effect endothelial
NF-kB activation. Furthermore, these studies provide mechanistic
insight into the role of TFA in mediating endothelial dysfunction
leading to vascular disorders.
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